Frontier Capital Management’s AbbVie ABBV Stock Holding History

Frontier Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-54,437	Closed	-$3.56M	–	363
2014 Q4	$3.56M	Buy	54,437 +1,291	+2%	+$81.4K	0.03%	313
2014 Q3	$3.07M	Buy	53,146 +630	+1%	+$35K	0.02%	301
2014 Q2	$2.96M	Sell	52,516 -6,570	-11%	-$345K	0.02%	298
2014 Q1	$3.04M	Buy	59,086 +2,136	+4%	+$108K	0.02%	309
2013 Q4	$3.01M	Sell	56,950 -6,520	-10%	-$320K	0.02%	300
2013 Q3	$2.84M	Buy	63,470 +9,500	+18%	+$421K	0.02%	309
2013 Q2	$2.23M	Buy	+53,970	New	+$2.36M	0.02%	317

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Frontier Capital Management's ABBV Position: Q1 2015 in Review

Frontier Capital Management sold out of AbbVie (ABBV) in Q1 2015, closing a stake of 54,437 shares — an estimated $3.56M sold.

Frontier Capital Management first reported a position in ABBV in Q2 2013 and held it in 7 quarters. The position peaked at $3.56M in Q4 2014. 1,601 funds tracked by Wall St. Rank hold ABBV as of Q1 2015.

Frontier Capital Management reported no remaining AbbVie position as of Q1 2015 after selling out during the quarter.
Frontier Capital Management sold 54,437 AbbVie shares in Q1 2015, an estimated $3.56M.
Frontier Capital Management first reported a position in AbbVie in Q2 2013 and held it in 7 quarters.
Frontier Capital Management's AbbVie position peaked at $3.56M in Q4 2014.
1,601 funds tracked by Wall St. Rank held AbbVie as of Q1 2015.

Based on Frontier Capital Management's 13F filing for Q1 2015, filed 4 May 2015.